Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
[DOI] [PubMed] [Google Scholar] 189.Simpson I.A., Chundu K.R., Davies-Hill T., Honer W.G., Davies P
This model expresses Cre recombinase under the control of the neuron-specific Map2 promoter, allowing for targeted deletion of Slc25a39 upon tamoxifen induction (Fig
Free radicals are unstable molecules that can damage cells and contribute to aging and disease
SOLSTICE Trial Results Sponsored by AstraZeneca, the SOLSTICE trial enrolled 406 adults with type 2 diabetes across nine countries, including the United States
Verify current pricing, licensure, shipping states, and regulatory status directly with Pomegranate Health and your healthcare provider before starting any medication
US$ 28.88
US$ 28.02
US$ 21.21
US$ 24.25
